High power (80 W) potassium-titanyl-phosphate laser vaporization of the prostate in 66 high risk patients

Journal of Urology

Volumn 173, Issue 1, 2005, Pages 158-160

  Reich, Oliver ^a   Bachmann, Alexander ^b   Siebels, Michael ^a   Hofstetter, Alfons ^a   Stief, Christian G ^a   Sulser, Tullio ^b  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

Laser surgery; Prostate; Prostatic hyperplasia; Risk; Urinary tract

Indexed keywords

ANTICOAGULANT AGENT; POTASSIUM DERIVATIVE; POTASSIUM TITANYL PHOSPHATE; UNCLASSIFIED DRUG;

ADULT; AGED; ANTICOAGULATION; ARTICLE; BLEEDING DISORDER; CARDIOVASCULAR RISK; CATHETERIZATION; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HEMOSTASIS; HIGH RISK POPULATION; HUMAN; INTRAOPERATIVE PERIOD; LASER; LAVAGE; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; ORGAN SIZE; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECURRENT DISEASE; REOPERATION; SCORING SYSTEM; URETHRA DISEASE; URINE RETENTION; VAPORIZATION;

EID: 10344263965     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ju.0000146631.14200.d4     Document Type: Article

References (20)

1. Costello, A. J., Bowsher, W. G., Bolton, D. M., Braslis, K. G. and Burt, J.: Laser ablation of the prostate in patients with benign prostatic hypertrophy. Br J Urol, 69: 603, 1992
2. Muschter, R. and Hofstetter, A.: Interstitial laser therapy outcomes in benign prostatic hyperplasia. J Endourol, 9: 129, 1995
3. Gilling, P. J., Kennett, K., Das, A. K., Thompson, D. and Fraundorfer, M. R.: Holmium laser enucleation of the prostate (HoLEP) combined with transurethral tissue morcellation: an update on the early clinical experience. J Endourol, 12: 457, 1998
4. Malek, R. S., Barrett, D. M. and Kuntzman, R. S.: High-power potassium-titanyl-phosphate (KTP/532) laser vaporization prostatectomy: 24 hours later. Urology, 51: 254, 1998
5. Malek, R. S., Kuntzman, R. S. and Barrett, D. M.: High power potassium-titanyl-phosphate laser vaporization prostatectomy. J Urol, 163: 1730, 2000
6. Hai, M. A. and Malek, R. S.: Photoselective vaporization of the prostate: initial experience with a new 80 W KTP laser for the treatment of benign prostatic hyperplasia. J Endourol, 17: 93, 2003
7. Malek, R. S. and Nahen, K.: Photoselective vaporization of the prostate (PVP): KTP laser therapy of obstructive benign prostatic hyperplasia. AUA Update, 23: 153, 2004
8. Kuntzman, R. S., Malek, R. S., Barrett, D. M. and Bostwick, D. G.: Potassium-titanyl-phosphate laser vaporization of the prostate: a comparative functional and pathologic study in canines. Urology, 48: 575, 1996
9. Kuntzman, R. S., Malek, R. S., Barrett, D. M. and Bostwick, D. G.: High-power (60-watt) potassium-titanyl-phosphate laser vaporization prostatectomy in living canines and in human and canine cadavers. Urology, 49: 703, 1997
10. Reich, O., Bachmann, A., Schneede, P., Zaak, D., Sulser, T. and Hofstetter, A.: Experimental comparison of high power (80 W) potassium titanyl phosphate laser vaporization and transurethral resection of the prostate. J Urol, 171: 2502, 2004
11. Gurdal, M., Tekin, A., Yucebas, E. and Sengor, F.: Nd:YAG laser ablation plus transurethral resection for large prostates in high-risk patients. Urology, 62: 914, 2003
12. Mulcahy, J. J., Brandenburg, R. O., Pluth, J. R. and Greene, L. F.: Transurethral prostatic resection in patients with prosthetic cardiac valves. J Urol, 113: 6424, 1975
13. Kearon, C. and Hirsh, J.: Management of anticoagulation before and after elective surgery. N Engl J Med, 336: 1506, 1997
14. Bell, C. R., Murdock, P. J., Pasi, K. J. and Morgan, R. J.: Thrombotic risk factors associated with transurethral prostatectomy. BJU Int, 83: 984, 1999
15. Parr, N. J., Loh, C. S. and Desmond, A. D.: Transurethral resection of the prostate and bladder tumor without withdrawal of warfarin therapy. Br J Urol, 64: 623, 1989
16. Mueller, E. J.: Contact laser vaporization of the prostate in patients on chronic anticoagulant therapy. Tech Urol, 4: 156, 1998
17. Bolton, D. M. and Costello, A. J.: Management of benign prostatic hyperplasia by transurethral laser ablation in patients treated with warfarin anticoagulation. J Urol, 151: 79, 1994
18. van Melick, H. H. E., van Venrooij, G. E. P. M. and Boon, T. A.: Laser prostatectomy in patients on anticoagulant therapy or with bleeding disorders. J Urol, 170: 1851, 2003
19. Dotan, Z. A., Mor, Y., Leibovitch, I., Varon, D., Golomb, J., Duvdevani, M. et al: The efficacy and safety of perioperative low molecular weight heparin substitution in patients on chronic oral anticoagulant therapy undergoing transurethral prostatectomy for bladder outlet obstruction. J Urol, 168: 610, 2003
20. Tooher, R., Sutherland, P., Costello, A., Gilling, P., Rees, G. and Maddern, G.: A systematic review of holmium laser prostatectomy for benign prostatic hyperplasia. J Urol, 171: 1773, 2004